New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
06:24 EDTPCRXPacira Pharmaceuticals remains a top small cap pick at Jefferies
Jefferies says Pacira Pharmaceuticals remains a top small cap and raised its price target for shares to $24 from $22. The firm believes Pacira's recent financing was done at favorable terms and removes an overhang on the stock.
News For PCRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 2, 2015
09:22 EDTPCRXOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Amira Nature Foods (ANFI), up 8.6%... Stratasys (SSYS), up 3.6%... Magnum Hunter (MHR), up 3%. ALSO HIGHER: Mavenir Systems (MVNR), up 19.1% after Mitel (MITL) agrees to acquire Mavenir Systems for $560M... Athersys (ATHX), up 19.7% following license agreement and collaboration with Chugai... OHR Pharmaceutical (OHRP), up 11.4% following additional positive data from OHR-102 IMPACT study... NXP Semiconductors (NXPI), up 14% following merger agreement with Freescale Semiconductor (FSL). Freescale Semiconductor is up 9.1%... Mast Therapeutics (MSTX), up 7.7% following positive results from Vepoloxamer study. DOWN AFTER EARNINGS: JinkoSolar (JKS), down 4.7%... Scorpio Tankers (STNG), down 4.5%. ALSO LOWER: Lumber Liquidators (LL), down 24.2% following CBS' 60 Minutes says that the company is linked to health and safety violations... Aruba Networks (ARUN), down 1.7% after HP (HPQ) confirms deal to acquire Aruba Networks for $24.67... Pacira Pharmaceuticals (PCRX), down 14.4% after receiving complete response letter from FDA for sNDA in use of Exparel... 500.com (WBAI), down 14.4% after announcing that temporary suspension will adversely impact financial results.
06:33 EDTPCRXPacira receives complete response letter from FDA for sNDA in use of Exparel
Subscribe for More Information
February 26, 2015
10:00 EDTPCRXOn The Fly: Analyst Downgrade SummaryStarz
Subscribe for More Information
07:43 EDTPCRXPacira downgraded at BofA/Merrill
Subscribe for More Information
06:17 EDTPCRXPacira downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
February 25, 2015
07:26 EDTPCRXPacira price target raised to $135 from $111 at Brean Capital
Subscribe for More Information
February 24, 2015
06:43 EDTPCRXPacira sees FY15 Exparel revenue $310M-$330M
Subscribe for More Information
06:42 EDTPCRXPacira reports Q4 non-GAAP EPS 35c, consensus 28c
Reports Q4 revenue $61.8M, consensus $62.12M

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use